vigiGrade: A Tool to Identify Well-Documented Individual Case Reports and Highlight Systematic Data Quality Issues.
- Published in:
- Drug Safety, 2014, v. 37, n. 1, p. 65, doi. 10.1007/s40264-013-0131-x
- By:
- Publication type:
- Article
Works matching IS 01145916 AND DT 2014 AND VI 37 AND IP 1
Results: 7
1
2
Sexual Dysfunction associated with Second-Generation Antidepressants in Patients with Major Depressive Disorder: Results from a Systematic Review with Network Meta-Analysis.
- Published in:
- Drug Safety, 2014, v. 37, n. 1, p. 19, doi. 10.1007/s40264-013-0129-4
- By:
- Publication type:
- Article
3
EU's New Pharmacovigilance Legislation: Considerations for Biosimilars.
- Published in:
- Drug Safety, 2014, v. 37, n. 1, p. 9, doi. 10.1007/s40264-013-0121-z
- By:
- Publication type:
- Article
4
Anti-Tuberculosis Drug-Induced Liver Injury in Shanghai: Validation of Hy's Law.
- Published in:
- Drug Safety, 2014, v. 37, n. 1, p. 43, doi. 10.1007/s40264-013-0119-6
- By:
- Publication type:
- Article
5
Ongoing Challenges in Pharmacovigilance.
- Published in:
- Drug Safety, 2014, v. 37, n. 1, p. 1, doi. 10.1007/s40264-013-0123-x
- By:
- Publication type:
- Article
6
Comparing Time to Adverse Drug Reaction Signals in a Spontaneous Reporting Database and a Claims Database: A Case Study of Rofecoxib-Induced Myocardial Infarction and Rosiglitazone-Induced Heart Failure Signals in Australia.
- Published in:
- Drug Safety, 2014, v. 37, n. 1, p. 53, doi. 10.1007/s40264-013-0124-9
- By:
- Publication type:
- Article
7
Post-Approval Evaluation of Effectiveness of Risk Minimisation: Methods, Challenges and Interpretation.
- Published in:
- Drug Safety, 2014, v. 37, n. 1, p. 33, doi. 10.1007/s40264-013-0126-7
- By:
- Publication type:
- Article